
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MKKGY | OTC Markets | USD | Delayed | |
MRKd | BATS Europe | EUR | Delayed | |
0O14 | London | EUR | Real-time | |
MRCG | Milan | EUR | Real-time | |
MRCG | Derived | EUR | Real-time | |
MRCG | Frankfurt | EUR | Delayed | |
MRCG | Xetra | EUR | Delayed | |
MRCG | TradeGate | EUR | Delayed | |
MRCG | Vienna | EUR | Real-time |
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography resins, single-use systems, process chemicals, and excipients; and life science services, such as monoclonal antibodies, high-potency active pharmaceutical ingredients, antibody-drug conjugates, and viral and gene therapy products, as well as contract development, manufacturing, and testing services. Its Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, cardiovascular, metabolism, and endocrinology disorders; and provides general medicines, injection devices, and disease monitoring software. The Electronics segment supplies materials comprising thin films, patterning and planarization formulations, specialty gases, optronics, and optical metrology equipment for the semiconductor and display industries, as well as provides delivery systems and services. It has in-licensing agreements with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA is a subsidiary of E. Merck KG.
Name | Age | Since | Title |
---|---|---|---|
Michael Kleinemeier | 66 | 2019 | Independent Chairman of Supervisory Board |
Barbara Lambert | 62 | 2023 | Independent Member of Supervisory Board |
Anne Lange | 41 | 2019 | Employee Representative Member of Supervisory Board |
Daniel Thelen | 51 | 2019 | Independent Member of Supervisory Board |
Dietmar Oeter | 59 | 2014 | Employee Representative Member of Supervisory Board |
Christian Raabe | 61 | 2019 | Employee Representative Member of Supervisory Board |
Stefan Palzer | 56 | 2024 | Independent Supervisory Board Member |
Sandra Schwebke | 54 | 2024 | Employee Representative Supervisory Board Member |
Birgit Biermann | 52 | 2022 | Employee Representative Member of Supervisory Board |
Alexander Putz | 59 | 2020 | Employee Representative Member of Supervisory Board |
Michael Reinhart | 46 | 2024 | Employee Representative Member of Supervisory Board |
Katja Garcia Vila | 53 | 2024 | Independent Supervisory Board Member |
Susanne Schaffert | 58 | 2024 | Independent Supervisory Board Member |
Sven Vollrath | 47 | - | Employee Representative Member of Supervisory Board |
Simon Thelen | 45 | 2019 | Independent Member of Supervisory Board |
Carla Kriwet | 54 | 2024 | Independent Supervisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review